Moxe Health has raised $30 million in a Series B funding round led by Piper Sandler Merchant Banking and Vensana Capital, the company announced today.

“This latest round of funding not only validates but accelerates our mission,” Moxe Health CEO Dan Wilson said in a statement. “With the support of our new investors, Piper Sandler Merchant Banking and Vensana Capital, we can better support our customer growth and advance interoperability, which leads to smarter, high quality, more affordable healthcare.”

According to a release, the funds will be used to prioritize team expansion and technology investments to further advance Moxe Health’s clinical data exchange solutions.

In addition, as part of the round, Tom Schnettler and Kirk Nielsen will join Moxe’s Board of Directors.